These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4577416)

  • 1. Interferon sensitivity of Venezuelan equine encephalomyelitis virus.
    Jordan GW
    Infect Immun; 1973 Jun; 7(6):911-7. PubMed ID: 4577416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon induction and sensitivity as correlates to virulence of Venezuelan encephalitis viruses for hamsters.
    Jahrling PB; Navarro E; Scherer WF
    Arch Virol; 1976; 51(1-2):23-35. PubMed ID: 962587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved method for production of attenuated Venezuelan equine encephalomyelitis (TC-83 strain) vaccine.
    Cole FE; Pedersen CE; Robinson DM; Eddy GA
    J Clin Microbiol; 1976 Apr; 3(4):460-2. PubMed ID: 1262457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivated Venezuelan equine encephalomyelitis vaccine prepared from attenuated (TC-83 strain) virus.
    Cole FE; May SW; Eddy GA
    Appl Microbiol; 1974 Jan; 27(1):150-3. PubMed ID: 4809906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formalin-inactivated Venezuelan equine encephalomyelitis (Trinidad strain) vaccine produced in rolling-bottle cultures of chicken embryo cells.
    Cole FE; May SW; Robinson DM
    Appl Microbiol; 1973 Feb; 25(2):262-5. PubMed ID: 4694345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plaque size and virulence of attenuated Venezuelan equine encephalomyelitis virus after passage in various hosts.
    Hearn HJ; Jameson P
    Am J Epidemiol; 1971 Jul; 94(1):56-61. PubMed ID: 4934542
    [No Abstract]   [Full Text] [Related]  

  • 7. Homegeneity of Venezuelan encephalitis virion populations of hamster-virulent and benign strains, including the attenuated TC83 vaccine.
    Jahrling PB; Scherer WF
    Infect Immun; 1973 Jun; 7(6):905-10. PubMed ID: 4716548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to alpha/beta interferons correlates with the epizootic and virulence potential of Venezuelan equine encephalitis viruses and is determined by the 5' noncoding region and glycoproteins.
    Spotts DR; Reich RM; Kalkhan MA; Kinney RM; Roehrig JT
    J Virol; 1998 Dec; 72(12):10286-91. PubMed ID: 9811777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of alpha/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5' untranslated region.
    White LJ; Wang JG; Davis NL; Johnston RE
    J Virol; 2001 Apr; 75(8):3706-18. PubMed ID: 11264360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparative sensitivity of Venezuelan equine encephalomyelitis virus neutralization tests in chick embryos and in mice.
    KOPROWSKI H; LENNETTE EH
    J Bacteriol; 1946 Feb; 51():257-61. PubMed ID: 21018698
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combined use of interferon and various styrylquinolines in cell cultures and experimental arbovirus infections].
    Leont'eva NA; Fomina AN; Idrisova ZV; Shubladze AK; Galegov GA
    Vopr Virusol; 1972; 17(4):482-5. PubMed ID: 5086860
    [No Abstract]   [Full Text] [Related]  

  • 12. Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein.
    Kinney RM; Chang GJ; Tsuchiya KR; Sneider JM; Roehrig JT; Woodward TM; Trent DW
    J Virol; 1993 Mar; 67(3):1269-77. PubMed ID: 7679745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic and biologic characteristics of Venezuelan encephalitis virus strains including a possible new subtype, isolated from the Amazon region of Peru in 1971.
    Scherer WF; Anderson K
    Am J Epidemiol; 1975 Apr; 101(4):356-61. PubMed ID: 235839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of combination of different inducers on the refractory state in interferon production.
    Yershov FI; Tazulakhova EB; Novokhatsky AS
    Acta Virol; 1976 Feb; 20(1):15-22. PubMed ID: 7936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indirect mouse model for the evaluation of potential antiviral compounds: results with Venezuelan equine encephalomyelitis virus.
    Kuehne RW; Pannier WL; Stephen EL
    Antimicrob Agents Chemother; 1977 Apr; 11(4):683-7. PubMed ID: 856020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of different factors on interferon superinduction].
    Askarkhodzhaev NA; Tazulakhova EB; Ershov FI
    Antibiotiki; 1982 Jun; 27(6):437-9. PubMed ID: 6180684
    [No Abstract]   [Full Text] [Related]  

  • 17. Generation and characterization of closely related epizootic and enzootic infectious cDNA clones for studying interferon sensitivity and emergence mechanisms of Venezuelan equine encephalitis virus.
    Anishchenko M; Paessler S; Greene IP; Aguilar PV; Carrara AS; Weaver SC
    J Virol; 2004 Jan; 78(1):1-8. PubMed ID: 14671082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Properties of the attenuated strain 230 of Venezuelan equine encephalomyelitis virus].
    Pshenichnov VA; Lukin EP; Selivanenko GM; Dorokhina TV
    Vopr Virusol; 1991; 36(1):80-2. PubMed ID: 1858365
    [No Abstract]   [Full Text] [Related]  

  • 19. [Reproduction of the Venezuelan equine encephalomyelitis virus under conditions of low ionic strength].
    Sokolova TM; Tazulakhova IB; Grigorian SS; Ershov FI
    Vopr Virusol; 1974; (5):586-75. PubMed ID: 4216162
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of back passage of Venezuelan equine encephalomyelitis TC-83 vaccine virus on clinical, virologic, and immune responses in horses.
    Luedke AJ; Barber TL; Foster NM; Batalla D; Mercado S
    J Am Vet Med Assoc; 1972 Oct; 161(7):824-31. PubMed ID: 5074264
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.